| Impact of altered intestinal microbiota on chronic kidney disease progression E Castillo-Rodriguez, R Fernandez-Prado, R Esteras, MV Perez-Gomez, ... Toxins 10 (7), 300, 2018 | 146 | 2018 |
| Klotho, phosphate and inflammation/ageing in chronic kidney disease MC Izquierdo, MV Perez-Gomez, MD Sanchez-Niño, AB Sanz, ... Nephrology Dialysis Transplantation 27 (suppl_4), iv6-iv10, 2012 | 142 | 2012 |
| Nutrients turned into toxins: microbiota modulation of nutrient properties in chronic kidney disease R Fernandez-Prado, R Esteras, MV Perez-Gomez, C Gracia-Iguacel, ... Nutrients 9 (5), 489, 2017 | 103 | 2017 |
| Clarifying the concept of chronic kidney disease for non-nephrologists MV Perez-Gomez, LA Bartsch, E Castillo-Rodriguez, R Fernandez-Prado, ... Clinical kidney journal 12 (2), 258-261, 2019 | 95 | 2019 |
| The choice of hemodialysis membrane affects bisphenol A levels in blood E Bosch-Panadero, S Mas, D Sanchez-Ospina, V Camarero, ... Journal of the American society of nephrology 27 (5), 1566-1574, 2016 | 87 | 2016 |
| Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies? P Magalhães, M Pejchinovski, K Markoska, M Banasik, M Klinger, ... Scientific Reports 7 (1), 16915, 2017 | 86 | 2017 |
| Targeting inflammation in diabetic kidney disease: early clinical trials MV Perez-Gomez, MD Sanchez-Niño, AB Sanz, B Zheng, C Martin-Cleary, ... Expert opinion on investigational drugs 25 (9), 1045-1058, 2016 | 84 | 2016 |
| Horizon 2020 in diabetic kidney disease: the clinical trial pipeline for add-on therapies on top of renin angiotensin system blockade MV Perez-Gomez, MD Sanchez-Niño, AB Sanz, C Martín-Cleary, ... Journal of clinical medicine 4 (6), 1325-1347, 2015 | 68 | 2015 |
| Urine proteomics for prediction of disease progression in patients with IgA nephropathy M Rudnicki, J Siwy, R Wendt, M Lipphardt, MJ Koziolek, D Maixnerova, ... Nephrology Dialysis Transplantation 37 (1), 42-52, 2022 | 59 | 2022 |
| Combination use of medicines from two classes of renin–angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function R Esteras, MV Perez-Gomez, L Rodriguez-Osorio, A Ortiz, ... Therapeutic Advances in Drug Safety 6 (4), 166-176, 2015 | 58 | 2015 |
| Potential dangers of serum urate-lowering therapy MV Perez-Gomez, LA Bartsch, E Castillo-Rodriguez, R Fernandez-Prado, ... The American journal of medicine 132 (4), 457-467, 2019 | 49 | 2019 |
| Growth differentiation factor-15 preserves Klotho expression in acute kidney injury and kidney fibrosis L Valiño-Rivas, L Cuarental, MI Ceballos, A Pintor-Chocano, ... Kidney International 101 (6), 1200-1215, 2022 | 46 | 2022 |
| Hypertensive nephropathy: a major roadblock hindering the advance of precision nephrology S Carriazo, M Vanessa Perez-Gomez, A Ortiz Clinical kidney journal 13 (4), 504-509, 2020 | 42 | 2020 |
| Urinary Growth Differentiation Factor-15 (GDF15) levels as a biomarker of adverse outcomes and biopsy findings in chronic kidney disease MV Perez-Gomez, S Pizarro-Sanchez, C Gracia-Iguacel, S Cano, ... Journal of Nephrology, 1-14, 2021 | 38 | 2021 |
| Vitamin D and proteinuria: a critical review of molecular bases and clinical experience MV Pérez-Gómez, A Ortiz-Arduán, V Lorenzo-Sellares Nefrología (English Edition) 33 (5), 716-726, 2013 | 37 | 2013 |
| Advances in understanding the role of angiotensin-regulated proteins in kidney diseases AB Sanz, AM Ramos, MJ Soler, MD Sanchez-Niño, ... Expert Review of Proteomics 16 (1), 77-92, 2019 | 35 | 2019 |
| Phosphate, microbiota and CKD C Favero, S Carriazo, L Cuarental, R Fernandez-Prado, E Gomá-Garcés, ... Nutrients 13 (4), 1273, 2021 | 33 | 2021 |
| MYH9-related disease: it does exist, may be more frequent than you think and requires specific therapy R Fernandez-Prado, SM Carriazo-Julio, R Torra, A Ortiz, ... Clinical kidney journal 12 (4), 488-493, 2019 | 33 | 2019 |
| Dietary care for ADPKD patients: current status and future directions S Carriazo, MV Perez-Gomez, A Cordido, MA García-González, AB Sanz, ... Nutrients 11 (7), 1576, 2019 | 33 | 2019 |
| Pelacarsen for lowering lipoprotein (a): implications for patients with chronic kidney disease R Fernandez-Prado, MV Perez-Gomez, A Ortiz Clinical kidney journal 13 (5), 753-757, 2020 | 30 | 2020 |